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Abstract: Enteric diseases enter through the mouth and are usually spread by contaminated food, water or contact
with contaminated vomit or feces. Enteric infection encompasses all the infections of the intestinal tract. These
intestinal infections include organisms like Escherichia coli, Salmonella, Shigella, Klebsiella, Proteus etc. Out of
these, E. coli are one of the common causes of enteric infection. In spite the introduction of a wide variety of
antimicrobial agents against enteric diseases, life threatening infections caused by E. coli contributes to morbidity
and mortality in patients. The present study was conducted to determine the antibiotic sensitivity pattern of E. coli
obtained from stool samples and potentiation of antibiotic activity by citric acid against multiple drug resistant E.
coli. Out of the 200 isolates of E. coli, 150 were found to be resistant to one or more antibiotics tested. 0.05% and
0.1% citric acid was found to be effective in increasing the potency of the all the antibiotics used in the study.
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INTRODUCTION
Escherichia is a major cause of enteric infection and
urinary tract infection, a common component of microbial
intra-abdominal infections and an occasional cause of a
variety of other infections including pneumonia,
osteomyelitis, cellulitis, myosistis, septic arthritis and
sinusitis.
Although most strains of E. coli are harmless, several
are known to produce toxins that can cause diarrheal
side effects. Since the mid 1930s, clinically important
bacteria have been subjected to successive onslaughts
of antibacterial drugs; however in response the bacterial
population has overcome these attacks by the selection
of resistant variants or requires novel genetic material.
Although many communicable diseases have been
effectively contained, bacterial infections remain a major
cause of morbidity and mortality particularly in
developing countries. Moreover, in both developed and
developing countries, the risk of some serious bacterial
infections has increased because of treatments such as
chemotherapy for cancer and the emergence of diseases
such as human immunodeficiency virus (HIV) infection
and the acquired immunodeficiency syndrome (AIDS),
which impair the patient’s defenses against infection.
Antimicrobials have reduced the morbidity and improved
the survival of patients with bacterial infections and
remain essential for the treatment of many kinds of
bacterial diseases. However, the increasing prevalence
of strains of common pathogenic bacteria resistant to
widely available, affordable antimicrobials is, in many
cases, dangerously eroding their effectiveness. It is
hoped that by encouraging the appropriate use of
antimicrobials, the emergence and spread of antimicrobial
resistance may be delayed (WHO, 2001).
Inspite of all the efforts made towards the better
chemotherapeutic agent, the problem of overcoming the
development of resistance has not yet been solved.
Russell et al., 1986 studied the sensitivities of some outer
membrane protein (omp) and /or lipopolysaccharides
(LPS) mutants of E. coli to chorhexidine and some
quaternary ammonium compounds (QACs). He found that
chlorhexidine was highly active against all the strains
tested. The concentration of the compound was within
the narrow range of 1 to 2mg. He also studied the
comparative sensitivity of smooth, rough and deep rough
strains of E. coli to dibromopropamidine isethionate,
chorhexidine diacetate (CHA) and other QACs. CHA was
almost equally active in low concentration against all he
strains where as QAC like cetypyridinium chloride (CPC),
domiphen bromide and benzethoium chloride were most
active against the deep rough strains and least against
wild type and slightly rough stains (Russell et al., 1986).
In the same year he also studied the effect of three
phenolics and of a homologous series of esters of para-
hydroxybenzoic acid (the parabenes) on E. coli with
known deletions in outer membrane. Of the phenolics,
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chlorocresol was the most active and phenol the least,
with butyl-p-hydroxybenzoate the most effective
parabene.
Nagoba et al. (2002) treated non healing ulcers in leprosy
patients by citric acid. Nagoba et al. (2008) employed the
citric acid for the treatment of chronic wound infections
caused by antibiotic resistant E. coli. A total of 34 cases
of chronic wound infections yielding MAREC isolates
on culture were studied. The antibacterial effect of citric
acid against MAREC was evaluated in vitro by broth
dilution method. 3% of citric acid gel was applied to each
wound once daily until it healed completely. All 34 isolates
were inhibited by citric acid with minimum inhibitory
concentration in the range of 1500-2000 µg/ml. Topical
application of 3% citric acid to wounds resulted in the
elimination of MAREC from infected sites and successful
healing of wounds in all the 34 patients.
Tumane et al. (2006) studied the amtimicrobial activity of
citrus fruit juices against pathogenic bacteria. The study
showed that the growth of Salmonella typhimurium, S.
paratyphi, Shigella flexneri, Proteus mirabilis and P.
vulgaris was inhibited by 2% citric acid. Owing to this
fact an attempt was made to potentiate the antibiotic
activity by citric acid against drug resistant isolates of E.
coli isolated from the patients suffering from enteric
infections.
MATERIALS AND METHODS
Isolation and identification: Total of 200 E. coli isolates
extracted from the clinical samples of stool and urine from
both outdoor and indoor patients were aseptically
collected from different wards of GMC and IGMC during
the period of Jan. 2010-Dec. 2010. Organisms were
identified on the basis of colony morphology and cultural
characteristics according to Bergey’s manual of
determinative bacteriology, 9th edition. For identification
at molecular level, genomic DNA was extracted from the
isolates using DNA extraction kit (Bangalore Genie, India).
The 16s rRNA gene was amplified by PCR. PCR
amplification was performed followed by standard
procedure (30cycles of 30S at 940C, 30S at 550C and 2 min
at 720C) with Taq DNA polymerase. Then sequence
analysis was performed with the BLAST program.
Antibiotic susceptibility testing: Antibiotic susceptibility
testing was carried out by disk diffusion method of Bauer
et al. (1996) using Muller Hinton agar plates (Hi-media,
India). Well isolated colonies of E. coli isolates from
selective media plates were inoculated in the tube
containing 5ml tryptone soya broth (Hi-media, India) and
incubated at 370 C until it achieved or exceeded the
turbidity of 0.5 McFarland standards which
approximately corresponds to 108 CFU/ml. From the 5ml
broth, 1ml of E. coli culture was uniformly spread on
MHA plates and antibiotic disks were placed over it. The
antimicrobial discs used were Cefuroxim (CU), Cephalexin
(CP), Cefepime (CPM),  Amikacin (AK), Carbenicillin (CB),
Ofloxacin (OF), Gatifloxacin (GF), Levofloxacin (LE) and
Sparfloxacin (SC). E. coli ATCC 25922 was used as a
control strain. The diameter of zone of inhibition was
measured using the calibrated ruler and the results were
interpreted according to the CLSI standards.
Determination of minimum inhibitory concentration
(MIC) of citric acid: Before going to see the potentiating
effect of citric acid the present section deals with the
study of ‘in vitro’ antimicrobial effect of citric acid against
multiple drug resistant isolates of E. coli by micro broth
dilution and macro broth dilution methods. Here out of
200 isolates, 150 were found to be multiple drugs resistant.
For MIC of citric acid, all the 150 multiple drugs resistant
isolates of E. coli were used. For this Hi- sensitivity test
broth [M486] was procured from Hi-media, Mumbai, India.
MIC procedure for broth macro dilution method (NCCLS
dilution method M7-A2): This test was performed in
round bottom sterile glass test tubes (Borosil made). A
working citric acid solution of 20 mg/ml was prepared by
dissolving 200 mg of citric acid in 10 ml of sterile distilled
water, two fold dilutions were made in test tube containing
sterile distilled water. Then equal amount of double
strength sterile Hi-sensitivity broth was mixed in each
test tube and inoculated with 0.1ml inoculum. The set
was incubated at 37 0 C overnight. MIC was recorded
accordingly.
MIC procedure for broth micro dilution method (NCCLS
dilution method M7-A2): Two fold citric acid dilutions
were made in 96 well micro titer plates and each well
inoculated with 10µl of inoculums with micropipette. The
plates were incubated at 370C overnight. The MIC was
recorded accordingly.
Potentiation of antibiotic activity by citric acid: The
isolates which were found to be resistant to one or more
antibiotics were further studied for potentiation purpose.
Out of 200 isolates of E. coli, 150 were found to be multiple
drug resistant (MDR). For potentiation purpose different
concentrations of citric acid (Blank, 0.05%, 0.1%, 0.2%,
0.3%, 0.4%, 0.5%, 1% and 2%) were used.  All the 150
MDR were grown overnight. Within 15min after adjusting
the turbidity (0.5 McFarland Standards) of inoculums
suspension, a sterile cotton swab was dipped into it; the
swab was streaked over the entire surface of Muller Hinton
agar (MHA) medium containing different concentrations
of citric acid (0% bank to 2%). The antimicrobial discs
were applied over the plates as soon as possible. All the
plates were incubated at 370C overnight and results were
reported according to CLSL guidelines.
RESULTS AND DISCUSSION
Diseases classified as enteric enter through the mouth
and intestinal tract are usually spread by contaminated
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food, water or contact with contaminated vomit or feces.
The topic of enteric infection encompasses all the
infections of the intestinal tract. Symptoms similar to those
caused by pathogens may be produced by chemical
toxins in ingested foods and by allergic reactions to
certain food substances. The bacteria commonly involved
in enteric infections are E. coli, V. cholera, Salmonella
sp., Klebsiella pneumoniae, several species of Shigella
etc. Enteric infections are characterized by diarrhea,
abdominal discomfort, nausea, vomiting and anorexia. A
significant loss of fluid and electrolytes may result from
severe vomiting and diarrhea (Mosby’s Medical
Dictionary, 2009). In addition to acute risk of disease,
long term complications of enteric disease include
malnutrition, malabsorption of vital drugs and
immunological complications.
Food borne diseases affect people’s health and well being
as well as have an economic impact on individuals and
Nations. Diarrheal diseases have been a major public
health problem causing high morbidity and mortality
among the children (Bureau of Epidemiology, 2004).
Approximately one million cases of acute diarrhea and
more than 1,20,000 cases of food poisoning are reported
each year (Bureau of Epidemiology, 2004). Food is
considered as the main source of microorganism causing
diarrheal diseases (Rabbani and Greenough, 1999; Jay,
2000; Fang et al., 2003).
In the current investigation total of 200 E. coli isolates
were isolated from clinical samples of stool. A series of
biochemical, morphological and cultural tests (Table 1)
were conducted for the identification and characterization
of E. coli as outlined in Bergey’s manual of Determinative
bacteriology (9th edition). For confirm identification 16s
rRNA sequencing was carried out according to the
standard procedures. BLAST analysis revealed that the
given isolates are of E. coli.
Selection of antibiotics against any type of infection
should be based on antimicrobial susceptibility testing.
Periodic evaluation of antimicrobial activity of different
antibiotics is essential as the pattern of antibiotic
sensitivity may vary over short periods (Jones and
Thornsberry, 1982). Choice of treatment should be made
Gram staining Motility I MR VP C Oxidase H2S Catalase 
Glucose 
(Gas production) Lac Man 
Gram negative 
coccobacillus 
Sluggishly 
motile + + - - - - + + + + 
Table 1. Morphological, biochemical characteristics of E. coli.
I-Indole, MR-Methyl red, VP-Vogues Proskauer,C-Citrate, + Positive, - : Negative
Fig. 1. Resistance pattern of E. coli before potentiation.
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after the sensitivity of causative organisms has been
determined “in vitro”. Enteric diseases vary from place
to place from time to time and so their sensitivity to
different antimicrobial drugs also changes. Information
concerning the drug resistance pattern of the prevailing
pathogenic bacteria and the appearance of new resistant
characteristic is of utmost value for a proper selection of
antimicrobial agents for therapeutic purposes.
Unawareness of local drug resistant pattern in pathogens
may foster it use and often over use of antibiotic with
their all harmful consequences.
With regards to the antibiotic sensitivity pattern of
isolates in the present investigation, E. coli was found
to be highly resistant to first and second generation
cephalosporins like cefuroxime (95.33%), Cephalexin
(90.66%) and Cefepime (83.33%). Nitrofurantoin showed
70.66% resistance against E.coli.
The development of antimicrobial resistance is a natural
process which cannot be stopped but can be minimized
or reduced by some or the other way. So an attempt was
made to potentiate the activity of antibiotics by citric
acid against multiple drug resistant enteropathogenic E.
coli.
For this purpose we thought to systematically study the
effective concentration of citric acid against multiple drug
resistant E. coli “in vitro”. In the present investigation,
citric acid was tested against all the 150 multiple drug
resistant E. coli using micro broth dilution and macro
broth dilution methods. We found that citric acid alone
at a concentration of 1000 µg/ml (Micro broth dilution)
Fig 2. Sensitivity pattern of E. coli after potentiation with citric acid.
and 2500 µg/ml (Macro broth dilution) is highly active
against these enteric pathogens. Similar findings were
observed by Gomashe and Tumane, 2006.
On the basis of these findings we proceeded for
potentiation of preselected antibiotics with different
concentrations of citric acid (0.05%, 0.1%, 0.2%, 0.3%,
0.4%, 0.5%, 1% and 2%). we found that an effective
concentration of citric acid to potentiate the activity of
antibiotics was 0.05% and 0.1%. Combination of above
0.1% citric acid and antibiotic resulted in the complete
inhibition (Figs. 1 and 2).
After potentiation it has been found that all the E. coli
strains which were resistant or moderately sensitive
(intermediate) towards previously tested antibiotics
became sensitive when tested with 0.05% and 0.1% citric
acid. From the given study one may conclude that, a
small percentage of potentiating agents like citric acid
when used in combination with conventional drugs can
make a big impact on their sensitivity.
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